Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial
- 30 March 2021
- journal article
- research article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 62 (3) , E373-E379
Abstract
Background: Melasma is one of the common pigmentary problems affecting females in our community, owing to the frequent use of hormonal contraceptives as well as our sunny climate. A lot of treatment options are available but none of them is completely satisfactory. Many patients prefer the use of topical preparations and minimally invasive methods. Tranexamic acid (TA) is a potential treatment option for hyperpigmentation with different delivery routes.Aim: We designed the study in order to evaluate the efficacy of TA in melasma using 2 different routes of delivery.Patients and methods: A randomised clinical trial was performed on 60 female patients with melasma, they randomly divided into three groups; A, B and C. Group (A) patients received TA (4 mg/mL) intradermal injections every 2 weeks with, group B received TA (10 mg/mL) intradermal injections every 2 weeks, group C received TA cream (10% concentration) twice daily, treatment continued for 12 weeks in all groups. Melasma Area and Severity Index (MASI) scores were measured for each patient before and after completion of treatment.Results: The percentage of MASI score reduction was highest in group B (62.7%) versus (39.1%) in group A, while the percentage of MASI reduction was the lowest in group C (4.2%).Conclusion: Tranexamic acid is a safe effective and well‐tolerated treatment option for melasma patients. Intradermal injection of TA leads to better results than the topical application. Topical TA cream (even in a high concentration) produce fair improvement of melasma.Keywords
This publication has 16 references indexed in Scilit:
- Efficacy and possible mechanisms of topical tranexamic acid in melasmaClinical and Experimental Dermatology, 2016
- Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical studyJournal of Dermatological Treatment, 2015
- Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasmaJournal of Cosmetic Dermatology, 2015
- Oral Tranexamic Acid for the Treatment of MelasmaKathmandu University Medical Journal, 2014
- Tranexamic acid: an important adjuvant in the treatment of melasmaJournal of Cosmetic Dermatology, 2013
- Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laserJournal of Dermatological Treatment, 2011
- Melasma: A comprehensive updateJournal of the American Academy of Dermatology, 2011
- The treatment of melasma: A review of clinical trialsJournal of the American Academy of Dermatology, 2006
- Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical TrialDermatologic Surgery, 2006
- Topical Retinoic Acid (Tretinoin) for Melasma in Black PatientsArchives of Dermatology, 1994